If you could vote on Brexit now which option would you choose?

COVID-19: AstraZeneca requests emergency authoritisation in US or drug that reduces risk of developing coronavirus symptoms by 77%

AstraZeneca has requested US authorisation for emergency use of its new treatment to prevent COVID-19 in people who have a lessened response to vaccines because of a weakened immune system. The drugmaker included data in its filing with the Food and Drug Administration from a late-stage trial showing the jab reduced the risk of people developing any coronavirus symptoms by 77%. The antibody therapy, called AZD7442, could be used to protect people who do not have a strong enough immune response to COVID vaccines, or as a booster for those such as military personnel, AstraZeneca said.

Sky News - October 5, 2021

View the full story here: https://news.sky.com/story/covid-19-astrazeneca-requests-emergency-authoritisation-in-us-or-drug-that-reduces-risk-of-developing-coronavirus-symptoms-by-77-12426338